[HTML][HTML] The interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancer
K Lee, AG Piazza - Journal of biomedical research, 2017 - ncbi.nlm.nih.gov
The activation of the Wnt/β-catenin signaling cascade has been well studied and
documented in colorectal cancer (CRC). The long-term use of non-steroidal anti …
documented in colorectal cancer (CRC). The long-term use of non-steroidal anti …
Mechanistic aspects of COX-2 expression in colorectal neoplasia
Abstract The cyclooxygenase-2 (COX-2) enzyme catalyzes the rate-limiting step of
prostaglandin formation in pathogenic states and a large amount of evidence has …
prostaglandin formation in pathogenic states and a large amount of evidence has …
β-Catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors
J Pannequin, N Delaunay, M Buchert, F Surrel… - Gastroenterology, 2007 - Elsevier
Background & Aims: Aberrant activation of the β-catenin/Tcf-4 transcriptional complex
represents an initiating event for colorectal carcinogenesis, shifting the balance from …
represents an initiating event for colorectal carcinogenesis, shifting the balance from …
WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth
D Wang, JR Mann, RN DuBois - Cell Cycle, 2004 - Taylor & Francis
Both Wnt and cyclooxygenase (COX-2) pathways are activated in most sporadic and familial
colorectal cancers, especially in those with chromosomal instability. We have recently …
colorectal cancers, especially in those with chromosomal instability. We have recently …
Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox‐2
IA Voutsadakis - Journal of cellular and molecular medicine, 2007 - Wiley Online Library
• Introduction• APC and the Wnt pathway• K‐ras initiated pathways• The TGF‐β pathway•
P53 and its functional regulation and dysregulation in colorectal cancer• The ubiquitin …
P53 and its functional regulation and dysregulation in colorectal cancer• The ubiquitin …
[HTML][HTML] Prostaglandin E2-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment
T Aoki, S Narumiya - Inflammation and regeneration, 2017 - Springer
Background Colorectal cancer is the third most common cancer. Involvement of
prostaglandin (PG) system in the pathogenesis of colorectal cancer has been suggested …
prostaglandin (PG) system in the pathogenesis of colorectal cancer has been suggested …
Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse
NF Paoni, MW Feldman, LS Gutierrez… - Physiological …, 2003 - journals.physiology.org
Mutations in the adenomatous polyposis coli (APC) gene that result in excessive β-catenin-
induced cell signaling are implicated in the risk of colon cancer. Although the mechanism of …
induced cell signaling are implicated in the risk of colon cancer. Although the mechanism of …
Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis
Multiple intracellular signaling pathways, such as Wnt/β-catenin signaling, epidermal growth
factor receptor/Ras signaling, and p53 signaling are frequently dysregulated in colorectal …
factor receptor/Ras signaling, and p53 signaling are frequently dysregulated in colorectal …
[HTML][HTML] Role of cyclooxygenase-2 in colorectal cancer
Cyclooxygenase-2 (COX-2) is an inducible enzyme which triggers the biosynthesis of
prostaglandins. COX-2 is activated in response to inflammatory stimuli and is one of the …
prostaglandins. COX-2 is activated in response to inflammatory stimuli and is one of the …
Signaling pathways for TNFa-induced COX-2 expression: mediation through MAP kinases and NFkB, and inhibition by certain nonsteroidal anti-inflammatory drugs
J Paik, JY Lee, D Hwang - Eicosanoids and Other Bioactive Lipids in …, 2002 - Springer
Colorectal adenocarcinoma is the most common cancer in North America and the second
leading cause of cancer death in the USA (American Cancer Society, 1990). The expression …
leading cause of cancer death in the USA (American Cancer Society, 1990). The expression …